DocGo Inc. (DCGO) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
17/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
LoseDCGO / S&P -17.97% / 15.20% |
LoseDCGO / S&P -32.40% / 15.00% |
WinDCGO / S&P 921.05% / 50.40% |
| 2026-Q11/3 |
LoseDCGO / S&P -28.36% / -4.33% |
LoseDCGO / S&P -42.03% / 11.30% |
WinDCGO / S&P 9350.00% / 27.70% |
| 2025-Q40/3 |
LoseDCGO / S&P -35.44% / 2.65% |
LoseDCGO / S&P -47.74% / 9.00% |
LoseDCGO / S&P -1176.47% / 13.40% |
| 2025-Q30/3 |
LoseDCGO / S&P -13.38% / 8.12% |
LoseDCGO / S&P -47.03% / 4.61% |
LoseDCGO / S&P -285.71% / 13.45% |
| 2025-Q20/3 |
LoseDCGO / S&P -40.53% / 10.94% |
LoseDCGO / S&P -41.31% / 4.83% |
LoseDCGO / S&P -167.86% / 10.63% |
| 2025-Q10/3 |
LoseDCGO / S&P -37.74% / -4.27% |
LoseDCGO / S&P -26.00% / 4.98% |
LoseDCGO / S&P -110.00% / 10.57% |
| 2024-Q42/3 |
WinDCGO / S&P 27.71% / 2.41% |
LoseDCGO / S&P -1.24% / 5.25% |
WinDCGO / S&P 142.86% / 6.15% |
| 2024-Q33/3 |
WinDCGO / S&P 7.44% / 5.89% |
WinDCGO / S&P 30.19% / 5.89% |
WinDCGO / S&P 180.00% / 6.11% |
| 2024-Q22/3 |
LoseDCGO / S&P -23.51% / 4.28% |
WinDCGO / S&P 64.49% / 5.38% |
WinDCGO / S&P 250.00% / 5.12% |
| 2024-Q11/3 |
LoseDCGO / S&P -27.73% / 10.56% |
WinDCGO / S&P 61.46% / 5.71% |
LoseDCGO / S&P -4.76% / 5.59% |
| 2023-Q41/3 |
LoseDCGO / S&P 4.88% / 11.69% |
WinDCGO / S&P 41.72% / 6.81% |
LoseDCGO / S&P -78.79% / 7.78% |
| 2023-Q31/3 |
LoseDCGO / S&P -43.12% / -3.27% |
WinDCGO / S&P 17.83% / 7.52% |
LoseDCGO / S&P -79.17% / -5.03% |
| 2023-Q20/3 |
LoseDCGO / S&P 8.32% / 8.74% |
LoseDCGO / S&P 3.92% / 9.50% |
LoseDCGO / S&P -83.67% / -8.57% |
| 2023-Q12/3 |
WinDCGO / S&P 22.35% / 7.50% |
WinDCGO / S&P 12.50% / 10.77% |
LoseDCGO / S&P -101.18% / -15.69% |
| 2022-Q41/3 |
LoseDCGO / S&P -28.73% / 7.56% |
WinDCGO / S&P 38.08% / 11.88% |
LoseDCGO / S&P -101.84% / -17.99% |
| 2022-Q31/3 |
WinDCGO / S&P 38.94% / -4.88% |
LoseDCGO / S&P DCGO unavailable / 13.47% |
LoseDCGO / S&P DCGO unavailable / -1.41% |
| 2022-Q20/3 |
LoseDCGO / S&P -22.81% / -16.10% |
LoseDCGO / S&P DCGO unavailable / 13.71% |
LoseDCGO / S&P DCGO unavailable / 11.04% |
| 2022-Q11/3 |
WinDCGO / S&P -1.07% / -4.60% |
LoseDCGO / S&P DCGO unavailable / 15.97% |
LoseDCGO / S&P DCGO unavailable / 42.23% |
| 2021-Q40/3 |
LoseDCGO / S&P -6.12% / 11.03% |
LoseDCGO / S&P DCGO unavailable / 15.00% |
LoseDCGO / S&P DCGO unavailable / 96.40% |
| 2021-Q30/3 |
LoseDCGO / S&P 0.20% / 0.58% |
LoseDCGO / S&P DCGO unavailable / 10.77% |
LoseDCGO / S&P DCGO unavailable / 69.42% |
| 2021-Q20/3 |
LoseDCGO / S&P 0.91% / 8.55% |
LoseDCGO / S&P DCGO unavailable / 6.58% |
LoseDCGO / S&P DCGO unavailable / 51.81% |
| 2021-Q10/3 |
LoseDCGO / S&P -3.00% / 6.17% |
LoseDCGO / S&P DCGO unavailable / -1.06% |
LoseDCGO / S&P DCGO unavailable / 7.39% |
| 2020-Q40/3 |
LoseDCGO / S&P DCGO unavailable / 12.15% |
LoseDCGO / S&P DCGO unavailable / -3.72% |
LoseDCGO / S&P DCGO unavailable / -33.42% |
| 2020-Q30/3 |
LoseDCGO / S&P DCGO unavailable / 8.93% |
LoseDCGO / S&P DCGO unavailable / -2.04% |
LoseDCGO / S&P DCGO unavailable / -27.10% |
| 2020-Q20/3 |
LoseDCGO / S&P DCGO unavailable / 20.54% |
LoseDCGO / S&P DCGO unavailable / -0.46% |
LoseDCGO / S&P DCGO unavailable / -27.11% |
| 2020-Q10/3 |
LoseDCGO / S&P DCGO unavailable / -19.60% |
LoseDCGO / S&P DCGO unavailable / 3.47% |
LoseDCGO / S&P DCGO unavailable / -14.75% |
| 2019-Q40/3 |
LoseDCGO / S&P DCGO unavailable / 9.07% |
LoseDCGO / S&P DCGO unavailable / 5.36% |
LoseDCGO / S&P DCGO unavailable / 2.99% |
| 2019-Q30/3 |
LoseDCGO / S&P DCGO unavailable / 1.70% |
LoseDCGO / S&P DCGO unavailable / 5.02% |
LoseDCGO / S&P DCGO unavailable / 0.21% |
| 2019-Q20/3 |
LoseDCGO / S&P DCGO unavailable / 4.30% |
LoseDCGO / S&P DCGO unavailable / 6.64% |
LoseDCGO / S&P DCGO unavailable / 8.65% |
| 2019-Q10/3 |
LoseDCGO / S&P DCGO unavailable / 13.65% |
LoseDCGO / S&P DCGO unavailable / 8.12% |
LoseDCGO / S&P DCGO unavailable / 14.29% |
| 2018-Q40/3 |
LoseDCGO / S&P DCGO unavailable / -13.52% |
LoseDCGO / S&P DCGO unavailable / 9.05% |
LoseDCGO / S&P DCGO unavailable / 18.23% |
| 2018-Q30/3 |
LoseDCGO / S&P DCGO unavailable / 7.71% |
LoseDCGO / S&P DCGO unavailable / 10.21% |
LoseDCGO / S&P DCGO unavailable / 19.06% |
| 2018-Q20/3 |
LoseDCGO / S&P DCGO unavailable / 3.43% |
LoseDCGO / S&P DCGO unavailable / 9.03% |
LoseDCGO / S&P DCGO unavailable / 14.46% |
| 2018-Q10/3 |
LoseDCGO / S&P DCGO unavailable / -0.76% |
LoseDCGO / S&P DCGO unavailable / 7.68% |
LoseDCGO / S&P DCGO unavailable / 12.46% |
| 2017-Q40/3 |
LoseDCGO / S&P DCGO unavailable / 6.64% |
LoseDCGO / S&P DCGO unavailable / 7.03% |
LoseDCGO / S&P DCGO unavailable / 13.82% |
| 2017-Q30/3 |
LoseDCGO / S&P DCGO unavailable / 4.48% |
LoseDCGO / S&P DCGO unavailable / 5.68% |
LoseDCGO / S&P DCGO unavailable / 17.57% |
| 2017-Q20/3 |
LoseDCGO / S&P DCGO unavailable / 3.09% |
LoseDCGO / S&P DCGO unavailable / 4.83% |
LoseDCGO / S&P DCGO unavailable / 17.74% |
| 2017-Q10/3 |
LoseDCGO / S&P DCGO unavailable / 6.07% |
LoseDCGO / S&P DCGO unavailable / 3.67% |
LoseDCGO / S&P DCGO unavailable / 13.32% |
| 2016-Q40/3 |
LoseDCGO / S&P DCGO unavailable / 3.82% |
LoseDCGO / S&P DCGO unavailable / 2.09% |
LoseDCGO / S&P DCGO unavailable / 7.05% |
| 2016-Q30/3 |
LoseDCGO / S&P DCGO unavailable / 3.85% |
LoseDCGO / S&P DCGO unavailable / 0.20% |
LoseDCGO / S&P DCGO unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | DCGO total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -73.40% | 20.78% |
| Annualized return | -73.40% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | DCGO total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -95.83% | 83.14% |
| Annualized return | -47.04% | 12.86% |
10Y · 2020-12-17 to 2026-08-27
| Metric | DCGO total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -95.97% | 319.30% |
| Annualized return | -27.47% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |